Αρχική Uncategorized Benefits of Regular Breast Cancer Screening Outweigh Risks of Overdiagnosis, New Paper...

Benefits of Regular Breast Cancer Screening Outweigh Risks of Overdiagnosis, New Paper Says

Breast cancer overdiagnosis can lead to harmful effects including psychological stress, complications of treatment, or adverse effects from diagnostic procedures. However, a paper out of Australia says the benefits of regular population screening outweigh these harms.

Authors led by Dr. Vivienne Milch, Medical Director of Cancer Australia, wrote a perspective on overdiagnosis within the country’s national population screening program for the Medical Journal of Australia. They say that the benefits of regular mammography, including lives saved, need to be considered within the discussion.


An overdiagnosed cancer is one that would not otherwise have gone on to cause death. The authors explain that doctors are able to diagnose cancer at increasingly early stages, and it won’t be known if a cancer will cause death unless the person with the tumor dies for another reason.

They write, “The reality that a proportion of cancers will therefore be overdiagnosed is inherent in all screening programs, although the issue is not limited to screening. Major international reviews have concluded, after a careful evaluation of the balance between benefits and harms, that there is a net benefit from inviting women to receive breast screening (ie, benefits outweigh harms).”

The authors explain that the stress of a diagnosis and the physical fallout of medical procedures do cause harm. However, they say there is little difference at diagnosis between cancers that will prove deadly and those that won’t. On the flip side, the authors say Australia’s national screening program saves lives.


The authors write, “Based on British and European reviews, Cancer Australia has estimated that for every 1000 Australian women screened for breast cancer every 2 years from age 50 to 74 years, around eight breast cancers may be found and treated which would not otherwise have been found in a woman’s lifetime. In addition, an equivalent number of breast cancer deaths would be avoided in these women.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

They added that the European Screening Network Working Group says that an estimated 6.5% of breast cancer cases in screened women will be overdiagnosed. Worldwide data shows that being invited for a screening results in a 23% lower mortality rate for women with breast cancer, and women who do schedule their mammograms have a 40% lower mortality rate.

While it’s difficult for doctors to be sure if a tumor will have slow growth or be aggressive, the authors write, “The concern is that the potential to discourage women from breast screening through concerns of overdiagnosis would result in harms associated with later diagnosis, including deaths from breast cancer. Based on current international evidence, if left untreated, more than 90% of cancers found through routine screening would progress and become symptomatic and be potentially lethal, depending on modelling assumptions.”

They added that even with higher estimates of overdiagnosis, more than 70% of invasive cancers detected during screening would become symptomatic without treatment.


The authors noted that if doctors follow evidence-based clinical management guidelines, the risk of overtreatment is much lower. In addition, breast cancer is increasingly being tailored to the patient’s specific situation, which can help address overtreatment, as well.

Going forward, the authors said there are currently studies being conducted on active monitoring as an alternative to surgery for ductal carcinoma in situ. There’s also ongoing investigation into whether genomic or other molecular signals in tumors may give a sign of how aggressively cancer may behave.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...